Aerojet, part of GenCorp Inc. of California, said development comes under a contract from the U.S. Missile Defense Agency.
"This development contract will advance SDACS technology to increase flight duration, mission flexibility and overall performance required for the SM-3 IIB missile, ultimately reducing technical risk for the future SM-3 IIB Missile Product Development Phase," Aerojet said.
"This SDACS Risk Reduction Technology Program is a key element of MDA's strategy for early demonstration of shipboard-compatible technologies for the SM-3 IIB missile that can be based on land or at sea."
The SM-3 Block IIB missile is a key component of Phase IV of the U.S. government's program to protect U.S. intercontinental ballistic missiles.
Workers accuse National Zoo of animal mismanagement
Wisconsin business offering 'therapeutic cuddling' forced to close